PubRank

Louis-Georges Ste-Marie

Author PubWeight™ 23.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Varying conceptions of competence: an analysis of how health sciences educators define competence. Med Educ 2012 1.94
2 Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 2009 1.85
3 Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician 2014 1.63
4 Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 2006 1.41
5 Mutations in NOTCH2 in families with Hajdu-Cheney syndrome. Hum Mutat 2011 1.25
6 Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 2005 1.14
7 High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep 2013 1.11
8 Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programme. Contemp Clin Trials 2007 0.98
9 Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res 2011 0.97
10 Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol 2008 0.90
11 Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial. Pituitary 2014 0.89
12 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6). Am J Physiol Endocrinol Metab 2004 0.85
13 Pamidronate prevents the development of skeletal metastasis in nude mice transplanted with human breast cancer cells by reducing tumor burden within bone. Int J Oncol 2003 0.84
14 Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. J Clin Endocrinol Metab 2007 0.82
15 Atypical femoral fractures and bone turnover. N Engl J Med 2011 0.82
16 Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture. Pharmacoepidemiol Drug Saf 2008 0.82
17 Role of zoledronic acid in the prevention and treatment of osteoporosis. Clin Interv Aging 2011 0.82
18 Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals. J Hypertens 2015 0.82
19 Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study. J Clin Densitom 2008 0.81
20 Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 2005 0.79
21 Microwave irradiation of ethanol-fixed bone improves preservation, reduces processing time, and allows both light and electron microscopy on the same sample. J Histochem Cytochem 2004 0.78
22 Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis. Int J Technol Assess Health Care 2002 0.76
23 Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia? Ther Apher Dial 2010 0.76
24 Validation of a decision model for preventive pharmacological strategies in postmenopausal women. Eur J Epidemiol 2005 0.76
25 Endocrine and bone consequences of cyclic nutritional changes in the calcium, phosphate and vitamin D status in the rat: an in vivo depletion-repletion-redepletion study. Bone 2007 0.75